ATE247458T1 - NEUE KÜGELCHEN MIT KONTROLLIERTER FREISETZUNG, EIN VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE FORMULIERUNG DES TYPS ßMULTIPLE UNITß - Google Patents

NEUE KÜGELCHEN MIT KONTROLLIERTER FREISETZUNG, EIN VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE FORMULIERUNG DES TYPS ßMULTIPLE UNITß

Info

Publication number
ATE247458T1
ATE247458T1 AT99971702T AT99971702T ATE247458T1 AT E247458 T1 ATE247458 T1 AT E247458T1 AT 99971702 T AT99971702 T AT 99971702T AT 99971702 T AT99971702 T AT 99971702T AT E247458 T1 ATE247458 T1 AT E247458T1
Authority
AT
Austria
Prior art keywords
production
controlled release
formulation containing
unit type
multiple unit
Prior art date
Application number
AT99971702T
Other languages
English (en)
Inventor
Torkel Gren
Anders Ringberg
Martin Wikberg
Randy J Wald
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247458(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/SE1999/001463 external-priority patent/WO2000012069A1/en
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of ATE247458T1 publication Critical patent/ATE247458T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
AT99971702T 1998-11-11 1999-11-11 NEUE KÜGELCHEN MIT KONTROLLIERTER FREISETZUNG, EIN VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE FORMULIERUNG DES TYPS ßMULTIPLE UNITß ATE247458T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (sv) 1998-11-11 1998-11-11 Therapeutic method and formulation
PCT/SE1999/001463 WO2000012069A1 (en) 1998-08-27 1999-08-26 Therapeutic formulation for administering tolterodine with controlled release
PCT/SE1999/002052 WO2000027364A1 (en) 1998-11-11 1999-11-11 New controlled release bead, a method of producing the same and multiple unit formulation comprising it

Publications (1)

Publication Number Publication Date
ATE247458T1 true ATE247458T1 (de) 2003-09-15

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971702T ATE247458T1 (de) 1998-11-11 1999-11-11 NEUE KÜGELCHEN MIT KONTROLLIERTER FREISETZUNG, EIN VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE FORMULIERUNG DES TYPS ßMULTIPLE UNITß

Country Status (40)

Country Link
US (1) US6911217B1 (de)
EP (1) EP1128819B1 (de)
JP (1) JP3616011B2 (de)
KR (1) KR100467384B1 (de)
CN (1) CN1169522C (de)
AP (1) AP1323A (de)
AR (1) AR027815A1 (de)
AT (1) ATE247458T1 (de)
AU (1) AU762410B2 (de)
BG (1) BG65149B1 (de)
BR (1) BRPI9915142B8 (de)
CA (1) CA2350061C (de)
CZ (1) CZ299582B6 (de)
DE (1) DE69910604T2 (de)
DK (1) DK1128819T3 (de)
EA (1) EA005074B1 (de)
EE (1) EE05232B1 (de)
ES (1) ES2204193T3 (de)
GE (1) GEP20022833B (de)
HK (1) HK1040917B (de)
HR (1) HRP20010333B1 (de)
HU (1) HU226582B1 (de)
ID (1) ID30039A (de)
IL (1) IL142809A0 (de)
IS (1) IS2370B (de)
MA (1) MA25325A1 (de)
MY (1) MY122195A (de)
NO (1) NO331399B1 (de)
NZ (1) NZ511430A (de)
OA (1) OA11673A (de)
PL (1) PL195780B1 (de)
PT (1) PT1128819E (de)
RS (1) RS49891B (de)
SE (1) SE9803871D0 (de)
SI (1) SI1128819T1 (de)
SK (1) SK284758B6 (de)
TW (2) TWI222879B (de)
UA (1) UA57165C2 (de)
WO (1) WO2000027364A1 (de)
ZA (1) ZA200103575B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU728395B2 (en) * 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (de) 1998-05-12 1999-11-17 Schwarz Pharma Ag 3,3-Diphenylpropylaminderivate
CN100353935C (zh) * 1999-11-11 2007-12-12 法马西雅公司 含托特罗定的药物制剂及其应用
MXPA05002302A (es) * 2002-08-28 2005-06-08 Pharmacia Corp Composicion liquida oral de tolterodina.
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MXPA05007767A (es) * 2003-01-22 2006-01-31 Pfizer Health Ab Dosis reducida de tolterodina y otros agentes antimuscarinicos para tratar trastornos urinarios.
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
ATE493981T1 (de) 2003-11-04 2011-01-15 Supernus Pharmaceuticals Inc Einmal tägliche dosierformen von trospium
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (de) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Pharmazeutische Zusammensetzung von Tolterodin mit verzögerter Freisetzung
EP1836156A1 (de) * 2005-01-10 2007-09-26 Teva Gyogyszergyar Reszvenytarsasag Im wesentlichen reines tolterodintartrat und verfahren zu dessen herstellung
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8298574B2 (en) 2006-01-18 2012-10-30 Intec Pharma Ltd. Method and apparatus for forming delivery devices for oral intake of an agent
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
KR100714058B1 (ko) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법
KR20080099334A (ko) * 2006-02-24 2008-11-12 테바 파마슈티컬 인더스트리즈 리미티드 메토프로롤 숙시네이트 서방정 및 이의 제조 방법
MX2008011952A (es) * 2006-03-21 2008-10-01 Teva Pharma Formulacion de liberacion controlad de tolterodina.
EP1839649A1 (de) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Beschichtete Formulierung von Tolterodine
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2026766A1 (de) 2006-05-17 2009-02-25 Synthon B.V. Tabletten-zusammensetzung mit verlängerter freisetzung von tamsulosin
ES2497494T3 (es) 2006-06-21 2014-09-23 Opko Renal, Llc Método de tratamiento y prevención del hiperparatiroidismo secundario
JP2008007458A (ja) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd レイヤリング用核粒子とその製造方法
MX2009005478A (es) 2006-11-27 2009-08-12 Lundbeck & Co As H Derivados de heteroarilamida.
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
US20090017111A1 (en) * 2007-07-03 2009-01-15 Van Den Heuvel Dennie J M Tolterodine bead
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
PL2187873T3 (pl) * 2007-08-13 2019-01-31 Abuse Deterrent Pharmaceutical Llc Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
WO2009140557A2 (en) * 2008-05-14 2009-11-19 Capricorn Pharma, Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
AU2010277207B2 (en) * 2009-07-31 2014-06-26 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
JP5736031B2 (ja) 2010-03-29 2015-06-17 フェリング ベスローテン フェンノートシャップ 速溶解性医薬組成物
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120289560A1 (en) * 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (el) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
AU2012307530B2 (en) 2011-09-16 2016-12-08 Ferring B.V. A fast dissolving pharmaceutical composition
WO2013047795A1 (ja) * 2011-09-30 2013-04-04 アステラス製薬株式会社 粒子状医薬組成物
AU2013289403B2 (en) 2012-07-12 2017-05-11 Ferring B.V. Diclofenac formulations
WO2014047477A2 (en) * 2012-09-20 2014-03-27 Sks Ocular, Llc Multilayer biodegradable microparticles for sustained release of therapeutic agents
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
WO2014159051A1 (en) * 2013-03-13 2014-10-02 Advanced Bionutrition Corp. Stable bioactive substances and methods of making
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US11571390B2 (en) 2013-03-15 2023-02-07 Othemo Life Sciences, Inc. Abuse deterrent compositions and methods of use
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
EP3193925A2 (de) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunktive therapie mit 25-hydroxyvitamin d
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA3018328A1 (en) * 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3431107A4 (de) * 2016-02-23 2019-11-13 Nipro Corporation Partikel einer pharmazeutischen zusammensetzung und im mund zerfallende zubereitung damit
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPH07107450A (ja) 1993-10-08 1995-04-21 Hitachi Ltd 情報通信装置
JP3453186B2 (ja) 1994-04-14 2003-10-06 共和薬品工業株式会社 徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
AU728395B2 (en) 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
TWI222879B (en) 2004-11-01
AP2001002166A0 (en) 2001-06-30
EA200100538A1 (ru) 2001-10-22
AR027815A1 (es) 2003-04-16
BRPI9915142B8 (pt) 2021-05-25
MA25325A1 (fr) 2001-12-31
DE69910604D1 (de) 2003-09-25
EE05232B1 (et) 2009-12-15
KR100467384B1 (ko) 2005-01-24
NZ511430A (en) 2003-05-30
DE69910604T2 (de) 2004-06-24
BR9915142A (pt) 2001-08-07
CA2350061A1 (en) 2000-05-18
OA11673A (en) 2005-01-12
HUP0105038A3 (en) 2006-07-28
EA005074B1 (ru) 2004-10-28
CZ299582B6 (cs) 2008-09-10
JP3616011B2 (ja) 2005-02-02
UA57165C2 (uk) 2003-06-16
NO331399B1 (no) 2011-12-19
AU1436600A (en) 2000-05-29
EP1128819B1 (de) 2003-08-20
IS5936A (is) 2001-05-09
DK1128819T3 (da) 2003-12-01
BRPI9915142B1 (pt) 2015-08-25
CN1169522C (zh) 2004-10-06
MY122195A (en) 2006-03-31
SI1128819T1 (en) 2003-12-31
WO2000027364A1 (en) 2000-05-18
TWI267385B (en) 2006-12-01
NO20012314L (no) 2001-07-09
SK284758B6 (sk) 2005-11-03
PL348612A1 (en) 2002-06-03
KR20010075695A (ko) 2001-08-09
SK6252001A3 (en) 2002-01-07
AP1323A (en) 2004-11-05
HK1040917A1 (en) 2002-06-28
EP1128819A1 (de) 2001-09-05
BG105582A (en) 2001-12-29
JP2003517446A (ja) 2003-05-27
PT1128819E (pt) 2003-12-31
HRP20010333A2 (en) 2003-04-30
NO20012314D0 (no) 2001-05-10
RS49891B (sr) 2008-08-07
ZA200103575B (en) 2002-05-03
HU226582B1 (en) 2009-04-28
ID30039A (id) 2001-11-01
IL142809A0 (en) 2002-03-10
AU762410B2 (en) 2003-06-26
HUP0105038A2 (en) 2002-06-29
HRP20010333B1 (en) 2004-10-31
CZ20011627A3 (cs) 2001-10-17
EE200100254A (et) 2002-12-16
PL195780B1 (pl) 2007-10-31
CA2350061C (en) 2005-05-17
IS2370B (is) 2008-06-15
BG65149B1 (bg) 2007-04-30
HK1040917B (zh) 2005-05-27
YU33101A (sh) 2003-10-31
ES2204193T3 (es) 2004-04-16
SE9803871D0 (sv) 1998-11-11
US6911217B1 (en) 2005-06-28
GEP20022833B (en) 2002-11-25
CN1326339A (zh) 2001-12-12

Similar Documents

Publication Publication Date Title
ATE247458T1 (de) NEUE KÜGELCHEN MIT KONTROLLIERTER FREISETZUNG, EIN VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE FORMULIERUNG DES TYPS ßMULTIPLE UNITß
DE69604218T2 (de) Druckmaterial, Verfahren zu deren Herstellung und Aufzeichnungsverfahren
ATE389388T1 (de) Zusammensetzungen mit verzoegerter freisetzung und verfahren zu deren herstellung
ATE317688T1 (de) Orale pharmazeutische zusammensetzung enthaltend ein benzimidazolderivat mit antiulcus wirkung und verfahren zu seiner herstellung
DE59809806D1 (de) Chemische mikroreaktoren und verfahren zu deren herstellung
DE69530989D1 (de) Neue pyrimidinderivate und verfahren zu ihrer herstellung
DE69611599T2 (de) Halbaromatische polyamidzusamensetzung und verfahren zu ihrer herstellung
DE69402051D1 (de) Wärmetauschelement, verfahren und vorrichtung zu dessen herstellung
ATE252542T1 (de) Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen,die diese enthalten
DE69800419D1 (de) Kapsel mit verlängerter Wirkstofffreisetzung und Verfahren zu ihrer Herstellung
ATE219069T1 (de) Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE242762T1 (de) Acrylonitril-derivate, verfahren zu ihrer herstellung und diese enthaltende schädlingsbekämpfungsmittel
ATE177732T1 (de) Benzylsulfid-derivate, verfahren zu deren herstellung und diese enthaltende schädlingsbekämpfungsmittel
DE60013901D1 (de) Photolithographisches verfahren, maskenrohlinge und verfahren zu deren herstellung
DE60022660D1 (de) Gasdichte beschichtungszusammensetzung, verfahren zu deren herstellung und gasdichter beschichtungsfilm
ATE234103T1 (de) Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
DE69815501D1 (de) Flachdruckplatte und verfahren zu deren herstellung
DE69739750D1 (de) Neue laktosamin-oligosaccharide und verfahren zu ihrer herstellung
DE69801795T2 (de) Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung
DE59805127D1 (de) Pulverlack-zusammensetzung, verfahren zu deren herstellung und deren verwendung
DE69513858T2 (de) Eine Silacyclohexanverbindung, ein Verfahren zu deren Herstellung und eine diese enthaltende flüssigkristalline Zusammensetzung
DE69905983D1 (de) Photoempfindliche Zusammensetzung, Verfahren zu ihrer Herstellung und Druckplattenmaterial
AT399880B (de) Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69421182D1 (de) Neue clathrat-verbindungen, verfahren zu ihrer herstellung und fäulmisverhinderndes mittel
DE59909123D1 (de) Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1128819

Country of ref document: EP